PS Ratio
180.16
+2.20+1.24%
Wed, 27 Nov 2024 23:28:13 GMT
Summary:
Celldex Therapeutics price to sales ratio is currently 180.16, with a rise of +2.20 (+1.24%) during the most recent trading day. Over the past year, it has dropped by -186.44 (-50.86%). CLDX PS ratio is now -91.55% below its all-time high of 2132.57.CLDX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +1.2% | +1.2% | +1.2% | +20.2% |
| 1 m1 month | -1.5% | -1.5% | -1.5% | - |
| 3 m3 months | -40.9% | -29.0% | -29.0% | - |
| 6 m6 months | -55.0% | -26.6% | -26.1% | - |
| ytdytd | -44.0% | -31.7% | -18.9% | - |
| 1 y1 year | -50.9% | -7.4% | +12.3% | +128.6% |
| 5 y5 years | +2024.5% | +1057.7% | +4661.7% | +124.2% |
CLDX PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 191.20 | -5.8% | 155.02 | +16.2% |
| 3 m | 3 months | 330.00 | -45.4% | 155.02 | +16.2% |
| 6 m | 6 months | 400.76 | -55.0% | 155.02 | +16.2% |
| 1 y | 1 year | 515.95 | -65.1% | 155.02 | +16.2% |
| 3 y | 3 years | 2132.57 | -91.5% | 155.02 | +16.2% |
| 5 y | 5 years | 2132.57 | -91.5% | 5.85 | +2979.7% |
| alltime | all time | 2132.57 | -91.5% | -41.22 | +537.1% |
Celldex Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2024 | 180.16(-44.0%) |
| 2023 | 322.00(-63.9%) |
| 2022 | 892.55(+129.9%) |
| 2021 | 388.15(+314.9%) |
| 2020 | 93.55(+783.4%) |
| 2019 | 10.59(+181.6%) |
| 2018 | 3.76(-87.8%) |
| 2017 | 30.87(-50.9%) |
| 2016 | 62.88(-77.7%) |
| 2015 | 282.32(-38.1%) |
| 2014 | 455.96(-13.2%) |
| 2013 | 525.58(+1263.4%) |
| 2012 | 38.55(+210.6%) |
| 2011 | 12.41(+340.1%) |
| 2010 | 2.82(-71.1%) |
| 2009 | 9.75(-41.9%) |
| 2008 | 16.77(-36.5%) |
| 2007 | 26.39(-76.1%) |
| 2006 | 110.54(+144.9%) |
| Date | Value |
|---|---|
| 2005 | 45.14(+111.7%) |
| 2004 | 21.32(-44.3%) |
| 2003 | 38.27(+276.3%) |
| 2002 | 10.17(-86.0%) |
| 2001 | 72.44(-85.9%) |
| 2000 | 514.81(+520.2%) |
| 1999 | 83.01(+139.9%) |
| 1998 | 34.60(-30.7%) |
| 1997 | 49.95(+85.3%) |
| 1996 | 26.96(+78.2%) |
| 1995 | 15.13(+148.4%) |
| 1994 | 6.09(-58.0%) |
| 1993 | 14.50(+58.1%) |
| 1992 | 9.17(-46.4%) |
| 1991 | 17.10(+581.3%) |
| 1990 | 2.51(-46.9%) |
| 1989 | 4.73(+69.5%) |
| 1988 | 2.79(-63.8%) |
| 1987 | 7.71(-75.0%) |
| 1986 | 30.85 |
FAQ
- What is Celldex Therapeutics price to sales ratio?
- What is the all time high PS ratio for Celldex Therapeutics?
- What is CLDX price to sales ratio year-to-date change?
- What is Celldex Therapeutics PS ratio year-on-year change?
What is Celldex Therapeutics price to sales ratio?
The current PS ratio of CLDX is 180.16
What is the all time high PS ratio for Celldex Therapeutics?
Celldex Therapeutics all-time high price to sales ratio is 2132.57
What is CLDX price to sales ratio year-to-date change?
Celldex Therapeutics price to sales ratio has changed by -141.84 (-44.05%) since the beginning of the year
What is Celldex Therapeutics PS ratio year-on-year change?
Over the past year, CLDX price to sales ratio has changed by -186.44 (-50.86%)